Uwe Muenster

1.7k total citations
23 papers, 1.2k citations indexed

About

Uwe Muenster is a scholar working on Pharmaceutical Science, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Uwe Muenster has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmaceutical Science, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Uwe Muenster's work include Drug Solubulity and Delivery Systems (12 papers), Inhalation and Respiratory Drug Delivery (6 papers) and Crystallization and Solubility Studies (5 papers). Uwe Muenster is often cited by papers focused on Drug Solubulity and Delivery Systems (12 papers), Inhalation and Respiratory Drug Delivery (6 papers) and Crystallization and Solubility Studies (5 papers). Uwe Muenster collaborates with scholars based in Germany, Greece and United Kingdom. Uwe Muenster's co-authors include Mark Jean Gnoth, Jennifer Dressman, Ulf Buetehorn, Thomas Schwarz, Steffen Sandmann, René Holm, Anette Müllertz, Shirui Mao, Edmund Kostewicz and Marcus E. Brewster and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Uwe Muenster

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Uwe Muenster Germany	14	650	226	215	182	157	23	1.2k
James Mann United Kingdom	19	858 1.3×	341 1.5×	146 0.7×	51 0.3×	230 1.5×	56	1.5k
Konstantinos Goumas Greece	16	841 1.3×	288 1.3×	224 1.0×	106 0.6×	199 1.3×	29	1.5k
Alfredo García‐Arieta Spain	16	488 0.8×	163 0.7×	92 0.4×	62 0.3×	112 0.7×	72	996
Rodrigo Cristofoletti United States	19	508 0.8×	195 0.9×	124 0.6×	38 0.2×	218 1.4×	88	1.1k
Nikunjkumar Patel United Kingdom	19	373 0.6×	105 0.5×	99 0.5×	31 0.2×	193 1.2×	36	795
Elke Lipka United States	16	512 0.8×	109 0.5×	417 1.9×	105 0.6×	355 2.3×	33	1.3k
Deanna M. Mudie United States	15	995 1.5×	330 1.5×	181 0.8×	61 0.3×	216 1.4×	20	1.5k
Ping Gao United States	23	1.6k 2.5×	629 2.8×	170 0.8×	34 0.2×	290 1.8×	37	2.2k
Jianghong Fan United States	20	202 0.3×	84 0.4×	357 1.7×	56 0.3×	423 2.7×	45	1.5k
Subhashis Chakraborty India	12	618 1.0×	101 0.4×	71 0.3×	76 0.4×	299 1.9×	21	1.2k

Countries citing papers authored by Uwe Muenster

Since Specialization

Citations

This map shows the geographic impact of Uwe Muenster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Muenster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Muenster more than expected).

Fields of papers citing papers by Uwe Muenster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Muenster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Muenster. The network helps show where Uwe Muenster may publish in the future.

Co-authorship network of co-authors of Uwe Muenster

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Muenster. A scholar is included among the top collaborators of Uwe Muenster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Muenster. Uwe Muenster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vertzoni, Maria, Sebastian Frechen, Juri Solodenko, et al.. (2025). Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 2: in vivo pharmacokinetic modeling of vericiguat. European Journal of Pharmaceutical Sciences. 212. 107189–107189. 1 indexed citations

Frechen, Sebastian, et al.. (2025). Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 1: in vitro modeling of vericiguat. European Journal of Pharmaceutical Sciences. 212. 107164–107164. 3 indexed citations

Vertzoni, Maria, et al.. (2020). Characteristics of Contents of Lower intestine in the 65–74 Years of Age Range Could Impact the Performance of Safe and Efficacious Modified Release Products. Journal of Pharmaceutical Sciences. 110(1). 251–258. 11 indexed citations

Zhang, Xiaofei, Qin Lu, Jian Su, et al.. (2020). Engineering large porous microparticles with tailored porosity and sustained drug release behavior for inhalation. European Journal of Pharmaceutics and Biopharmaceutics. 155. 139–146. 25 indexed citations

Li, Jiaqi, Huangliang Zheng, Qin Lu, et al.. (2019). In vitro–in vivo correlation of inhalable budesonide-loaded large porous particles for sustained treatment regimen of asthma. Acta Biomaterialia. 96. 505–516. 22 indexed citations

Butler, James, et al.. (2018). Application of a Refined Developability Classification System. Journal of Pharmaceutical Sciences. 108(3). 1090–1100. 22 indexed citations

Vertzoni, Maria, et al.. (2018). Evaluating the clinical importance of bacterial degradation of therapeutic agents in the lower intestine of adults using adult fecal material. European Journal of Pharmaceutical Sciences. 125. 142–150. 19 indexed citations

Zhang, Xiaofei, Jiaqi Li, Linlin Fan, et al.. (2018). Sustained therapeutic efficacy of budesonide-loaded chitosan swellable microparticles after lung delivery: Influence of in vitro release, treatment interval and dose. Journal of Controlled Release. 283. 163–174. 34 indexed citations

Mann, James, Jennifer Dressman, Karin M. Rosenblatt, et al.. (2017). Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study. Molecular Pharmaceutics. 14(12). 4192–4201. 75 indexed citations

10.

Ni, Rui, et al.. (2017). Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization. Journal of Controlled Release. 249. 11–22. 71 indexed citations

11.

Andersson, Sara, Jan Bevernage, Yan He, et al.. (2016). Interlaboratory Validation of Small-Scale Solubility and Dissolution Measurements of Poorly Water-Soluble Drugs. Journal of Pharmaceutical Sciences. 105(9). 2864–2872. 41 indexed citations

12.

Ni, Rui, et al.. (2016). Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery. European Journal of Pharmaceutical Sciences. 99. 137–146. 62 indexed citations

13.

Muenster, Uwe, et al.. (2016). Predicting biopharmaceutical performance of oral drug candidates – Extending the volume to dissolve applied dose concept. European Journal of Pharmaceutics and Biopharmaceutics. 102. 191–201. 7 indexed citations

14.

Karatza, Eleni, Maria Vertzoni, Uwe Muenster, & Christos Reppas. (2016). The Impact of Handling and Storage of Human Fecal Material on Bacterial Activity. Journal of Pharmaceutical Sciences. 105(11). 3458–3461. 9 indexed citations

15.

Andreas, Cord J., et al.. (2016). Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipine. European Journal of Pharmaceutics and Biopharmaceutics. 105. 193–202. 26 indexed citations

16.

Bergström, Christel A. S., René Holm, Sara Andersson, et al.. (2013). Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs. European Journal of Pharmaceutical Sciences. 57. 173–199. 206 indexed citations

17.

Kostewicz, Edmund, Bertil Abrahamsson, Marcus E. Brewster, et al.. (2013). In vitro models for the prediction of in vivo performance of oral dosage forms. European Journal of Pharmaceutical Sciences. 57. 342–366. 299 indexed citations

18.

Gnoth, Mark Jean, Ulf Buetehorn, Uwe Muenster, Thomas Schwarz, & Steffen Sandmann. (2011). In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban. Journal of Pharmacology and Experimental Therapeutics. 338(1). 372–380. 183 indexed citations

19.

Muenster, Uwe, Thomas Backensfeld, Thomas Kuhlmann, et al.. (2011). Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): Tools to predict in vivo bioavailability from orally applied drug suspensions. European Journal of Pharmaceutics and Biopharmaceutics. 78(3). 522–530. 12 indexed citations

20.

Muenster, Uwe, et al.. (2008). Characterization of Substrates and Inhibitors for the In Vitro Assessment of Bcrp Mediated Drug–Drug Interactions. Pharmaceutical Research. 25(10). 2320–2326. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact